Filed: 2/26/2026ACC: 0001013594-26-000305
📋 What this filing means
SEVEN FLEET CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 85 equity positions with a total reported market value of $131.48M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
85
Positions
$131.48M
Total AUM (reported)
7.63M
Total Shares
Allocation by class
COM$115.77M88.0%
COM NEW$8.96M6.8%
SPONSORED ADS$1.74M1.3%
SPONSORED ADR$1.21M0.9%
COM SHS$919.7K0.7%
ADS$897.4K0.7%
SHS$885.2K0.7%
Portfolio Concentration
Top 3$74.17M56.4%
4–10$17.49M13.3%
11–25$18.67M14.2%
Rest$21.15M16.1%
Top 3 weight
56.4%
Top 10 weight
69.7%
Voting Authority Distribution
Total shares with voting rights: 7.63M
Sole
Full voting authority
6.14M
shares
% of voting shares80.4%
Shared
Joint voting authority
1.49M
shares
% of voting shares19.6%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole85
Shared0
Other0
Dominant voting typeSole · 80.4% of voting shares
Institutional Holdings85
Rows:
CG ONCOLOGY INC
SOLEShares1.52M
TypeSH
Market value$62.91M
47.85%
Sole
75.76K
Shared
1.44M
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares130.08K
TypeSH
Market value$6.02M
4.58%
Sole
76.08K
Shared
54K
None
0.00
REVOLUTION MEDICINES INC
SOLEShares65.80K
TypeSH
Market value$5.24M
3.99%
Sole
65.80K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares91.27K
TypeSH
Market value$3.15M
2.39%
Sole
91.27K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares568.75K
TypeSH
Market value$3.05M
2.32%
Sole
568.75K
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares68.57K
TypeSH
Market value$3.01M
2.29%
Sole
68.57K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares12.96K
TypeSH
Market value$2.37M
1.80%
Sole
12.96K
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares79.56K
TypeSH
Market value$2.09M
1.59%
Sole
79.56K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares54.02K
TypeSH
Market value$1.92M
1.46%
Sole
54.02K
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares215.17K
TypeSH
Market value$1.91M
1.45%
Sole
215.17K
Shared
0.00
None
0.00
XENCOR INC
SOLEShares109.55K
TypeSH
Market value$1.68M
1.28%
Sole
109.55K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares55.34K
TypeSH
Market value$1.54M
1.17%
Sole
55.34K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares36.89K
TypeSH
Market value$1.49M
1.13%
Sole
36.89K
Shared
0.00
None
0.00
BELITE BIO INC
SOLEShares9.16K
TypeSH
Market value$1.47M
1.11%
Sole
9.16K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares70.18K
TypeSH
Market value$1.37M
1.04%
Sole
70.18K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares12.60K
TypeSH
Market value$1.27M
0.96%
Sole
12.60K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares5.67K
TypeSH
Market value$1.21M
0.92%
Sole
5.67K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares82.50K
TypeSH
Market value$1.17M
0.89%
Sole
82.50K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares25.36K
TypeSH
Market value$1.17M
0.89%
Sole
25.36K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares63.34K
TypeSH
Market value$1.15M
0.87%
Sole
63.34K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares533.65K
TypeSH
Market value$1.09M
0.83%
Sole
533.65K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares1.86K
TypeSH
Market value$1.08M
0.82%
Sole
1.86K
Shared
0.00
None
0.00
GERON CORP
SOLEShares777.88K
TypeSH
Market value$1.03M
0.78%
Sole
777.88K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares4K
TypeSH
Market value$986.2K
0.75%
Sole
4K
Shared
0.00
None
0.00
ATHIRA PHARMA INC
SOLEShares127.95K
TypeSH
Market value$968.6K
0.74%
Sole
127.95K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 1.52M | SH | $62.91M 47.85% | 75.76K | 1.44M | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 130.08K | SH | $6.02M 4.58% | 76.08K | 54K | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 65.80K | SH | $5.24M 3.99% | 65.80K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 91.27K | SH | $3.15M 2.39% | 91.27K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 568.75K | SH | $3.05M 2.32% | 568.75K | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 68.57K | SH | $3.01M 2.29% | 68.57K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 12.96K | SH | $2.37M 1.80% | 12.96K | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 79.56K | SH | $2.09M 1.59% | 79.56K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 54.02K | SH | $1.92M 1.46% | 54.02K | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 215.17K | SH | $1.91M 1.45% | 215.17K | 0.00 | 0.00 |
XENCOR INCSOLE | COM | 109.55K | SH | $1.68M 1.28% | 109.55K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 55.34K | SH | $1.54M 1.17% | 55.34K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 36.89K | SH | $1.49M 1.13% | 36.89K | 0.00 | 0.00 |
BELITE BIO INCSOLE | SPONSORED ADS | 9.16K | SH | $1.47M 1.11% | 9.16K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 70.18K | SH | $1.37M 1.04% | 70.18K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 12.60K | SH | $1.27M 0.96% | 12.60K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 5.67K | SH | $1.21M 0.92% | 5.67K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 82.50K | SH | $1.17M 0.89% | 82.50K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 25.36K | SH | $1.17M 0.89% | 25.36K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 63.34K | SH | $1.15M 0.87% | 63.34K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 533.65K | SH | $1.09M 0.83% | 533.65K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 1.86K | SH | $1.08M 0.82% | 1.86K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 777.88K | SH | $1.03M 0.78% | 777.88K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 4K | SH | $986.2K 0.75% | 4K | 0.00 | 0.00 |
ATHIRA PHARMA INCSOLE | COM | 127.95K | SH | $968.6K 0.74% | 127.95K | 0.00 | 0.00 |
Page 1 of 4